18F-HER2 PET

N/A

Report date: 2025/10/20 14:27:08

NME

Base Information

Drug Name18F-HER2 PET

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionAnti-HER2

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsCarcinoma, Transitional Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesFirst Affiliated Hospital Of Zhejiang University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Zhejiang University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Transitional Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A